Showing results (291-300 of 782) with videos related to

Sort By:
Pageof 79
The Lancet. HIV|February 29, 2024
Effect of screening for Neisseria gonorrhoeae and Chlamydia trachomatis on incidence of these infections in men who have sex with men and transgender women taking HIV pre-exposure prophylaxis (the Gonoscreen study): results from a randomised, multicentre, controlled trialThibaut Vanbaelen, Achilleas Tsoumanis, Eric Florence, et al.
The Lancet. HIV|December 10, 2023
Transitional community adherence support for people leaving incarceration in South Africa: a pragmatic, open-label, randomised controlled trialTonderai Mabuto, Daniel M Woznica, Pretty Ndini, et al.
The Lancet. HIV|December 11, 2023
Survival by sex and HIV status in patients with anal cancer in the USA between 2001 and 2019: a retrospective cohort studyJaimie Z Shing, Eric A Engels, April A Austin, et al.
The Lancet. HIV|November 9, 2023
Programme science: a route to effective coverage and population-level impact for HIV and sexually transmitted infection preventionLeigh M McClarty, Marissa L Becker, Patricia J García, et al.
The Lancet. HIV|July 26, 2024
The contribution of intimate partner violence to vertical HIV transmission: a modelling analysis of 46 African countriesSalome Kuchukhidze, Magdalene K Walters, Dimitra Panagiotoglou, et al.
The Lancet. HIV|August 26, 2024
Changes in bodyweight after initiating antiretroviral therapy close to HIV-1 seroconversion: an international cohort collaborationNikos Pantazis, Caroline A Sabin, Sophie Grabar, et al.
The Lancet. HIV|May 30, 2024
Dynamics of virological and immunological markers of HIV persistence after allogeneic haematopoietic stem-cell transplantation in the IciStem cohort: a prospective observational cohort studyMaria Salgado, Cristina Gálvez, Monique Nijhuis, et al.
The Lancet. HIV|July 8, 2024
Impact of a point-of-care urine tenofovir assay on adherence to HIV pre-exposure prophylaxis among women in Kenya: a randomised pilot trialMonica Gandhi, David V Glidden, Deepalika Chakravarty, et al.
The Lancet. HIV|October 6, 2023
Impact of differentiated service delivery models on 12-month retention in HIV treatment in Mozambique: an interrupted time-series analysisDorlim A Moiana Uetela, Orvalho Augusto, James P Hughes, et al.
The Lancet. HIV|October 2, 2023
Efficacy, safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir for HIV pre-exposure prophylaxis in transgender women: a secondary analysis of the HPTN 083 trialMark A Marzinke, Brett Hanscom, Zhe Wang, et al.
Pageof 79